< Back to previous page
Researcher
Eric Legius
- Disciplines:Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Neurofibromatosis Research (Division)
Member
From15 Jul 2022 → Today - Department of Human Genetics (Department)
Member
From1 Oct 1999 → 14 Jul 2022
Projects
1 - 10 of 19
- Monogenic immune disorders in adults: from Mendelian inheritance to somatic mosaicismFrom3 Oct 2022 → TodayFunding: FWO fellowships
- Importance of SPRED1 in melanomaFrom9 Dec 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- EU Patient- cEntric clinicAl tRial pLatformFrom1 Nov 2019 → 30 Apr 2023Funding: H2020 - European Institute of Innovation and Technology
- The effect of genetic factors on the severity of the ASD phenotypeFrom1 Sep 2018 → 1 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Importance of SPRED1 in melanomaFrom1 Jan 2017 → 30 Jun 2021Funding: Other federal scientific institutions
- Unraveling the genetics of familial SchwannomatosisFrom1 Oct 2016 → 30 Sep 2017Funding: Nonprofit institution or equivalents
- Importance of SPRED1 in melanomaFrom1 Oct 2015 → 27 Mar 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Periosteal cell therapy as a new treatment of pseudarthrosis in children with NF1.From21 Oct 2013 → 10 Dec 2019Funding: IWT personal funding - strategic basic research grants, BOF - Doctoral projects
- A molecular approach to understand breast cancer cell dormancy.From1 Oct 2012 → 4 Jul 2019Funding: FWO fellowships
- Pathogenesis of congenital tibial bowing and pseudarthrosis in neurofibromatosis type 1.From1 Jan 2012 → 31 Dec 2015Funding: FWO research project
Publications
21 - 30 of 214
- Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up(2021)
Authors: Eric Legius, Patrick Schöffski
Pages: 1520 - 1536 - Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up(2021)
Authors: Eric Legius, Patrick Schöffski
Pages: 1348 - 1365 - Identifying challenges in neurofibromatosis: a modified Delphi procedure(2021)
Authors: Eric Legius
Pages: 1625 - 1633 - TNPO2 variants associate with human developmental delays, neurologic deficits, and dysmorphic features and alter TNPO2 activity in Drosophila(2021)
Authors: Miel Theunis, Eric Legius
Pages: 1669 - 1691 - Lessons learned from drug trials in neurofibromatosis: A systematic review(2021)
Authors: Charlotte Carton, Eric Legius
- Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation(2021)
Authors: Eric Legius
Pages: 1506 - 1513 - MEK inhibition ameliorates social behavior phenotypes in a Spred1 knockout mouse model for RASopathy disorders(2021)
Authors: Sarah Borrie, Rudi D'Hooge, Eric Legius, Hilde Brems
- A Patient with neonatal cholestasis.(2021)
Authors: Kristl Claeys, Eric Legius, Hilde Brems, David Cassiman, Pieter Vermeersch, Elena Levtchenko
Pages: 31 - 33 - Impaired instrumental learning in Spred1-/- mice, a model for a rare RASopathy.(2021)
Authors: Sarah Borrie, Eric Legius, Hilde Brems
- Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies(2021)
Authors: Liesbeth Lenaerts, Nathalie Brison, Charlotte Maggen, Huiwen Che, Peter Vandenberghe, Daan Dierickx, Lucienne Michaux, Barbara Dewaele, Patrick Neven, Beppe Floris, et al.